Mucosal barrier injury laboratory-confirmed bloodstream infection: Results from a field test of a new national healthcare safety network definition

Infection Control and Hospital Epidemiology

Volumn 34, Issue 8, 2013, Pages 769-776

  See, Isaac ^a,b   Iwamoto, Martha ^a   Allen Bridson, Kathy ^a   Horan, Teresa ^a   Magill, Shelley S ^a   Thompson, Nicola D ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DIARRHEA; DISEASE SURVEILLANCE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAFT VERSUS HOST REACTION; HEALTH CARE; HOSPITAL; HOSPITAL PERSONNEL; HUMAN; KLEBSIELLA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPENIA; NEUTROPHIL COUNT; REVIEW; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS; STOMACH MUCOSA INJURY;

BACTEREMIA; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; CRITICAL CARE; CROSS INFECTION; DIARRHEA; FUNGEMIA; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS; HUMANS; LEUKOCYTE COUNT; MUCOUS MEMBRANE; NEUTROPENIA; NEUTROPHILS; POPULATION SURVEILLANCE; TERMINOLOGY AS TOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 84880053757     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/671281     Document Type: Review

References (14)

1. Pyrek KM. Public reporting of infections and the CLABSI mandate. Infect Control Today. January 17, 2011. http://www.infectioncontroltoday.com/articles/2011/01/public-reporting-of-infections-and-the-clabsi-mandate.aspx. Accessed January 9, 2013.
2. Fraser TG, Gordon SM. CLABSI rates in immunocompromised patients: a valuable patient centered outcome? Clin Infect Dis 2011;52(12):1446-1450.
3. Sexton DJ, Chen LF, Anderson DJ. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol 2010;31(12):1286-1289.
4. Worth LJ, Slavin MA, Brown GV, Black J. Catheter-related bloodstream infections in hematology: time for standardized surveillance? Cancer 2007;109(7):1215-1226.
5. Pehar M, Ristaino P, Budd AP, et al. Application of the National Healthcare Safety Network (NHSN) central line associated bloodstream infection (CLA-BSI) definition to oncology patients: impact in the trenches. In: Program and Abstracts of the Fifth Decennial International Conference on Healthcare-Associated Infections. March 18-22, 2010; Atlanta, GA. Abstract 660.
6. DiGiorgio MJ, Fatica C, Oden M, et al. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies. Infect Control Hosp Epidemiol 2012;33(9):865-868.
7. Freeman JT, Elinder-Camburn A, McClymont C, et al. Central line-associated bloodstream infections in adult hematology patients with febrile neutropenia: an evaluation of surveillance definitions using differential time to blood culture positivity. Infect Control Hosp Epidemiol 2013;34(1):89-92.
8. Steinberg JP, Robichaux C, Tejedor SC, Reyes MD, Jacob JT. Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition. Infect Control Hosp Epidemiol 2013;34(2):171-175.
9. Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000;25(12):1269-1278.
10. Central Line-Associated Bloodstream Infection (CLABSI) Event. National Healthcare Safety Network website. http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf. Accessed January 9, 2013.
11. CDC Locations and Descriptions-Patient Safety Component Manual. National Healthcare Safety Network website. http:// www.cdc.gov/nhsn/PDFs/pscManual/15LocationsDescriptions _current.pdf. Accessed January 9, 2013.
12. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-858.
13. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009;15(10):1143-1238.
14. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52(4):e56-e93.